Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Gsk (GSK)

Gsk Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:GSK
DateTimeSourceHeadlineSymbolCompany
23/07/202412:07Alliance NewsAlliance NewsGSK announces promising trial data for ViiV Healthcare HIV drugsLSE:GSKGsk Plc
23/07/202412:07Alliance NewsAlliance NewsGSK announces promising trial data for ViiV Healthcare HIV drugsLSE:GSKGsk Plc
19/07/202410:36RNS Regulatory NewsGSK PLC Blenrep EMA Filing AcceptanceLSE:GSKGsk Plc
19/07/202408:12Alliance NewsAlliance NewsGSK drug for multiple myeloma accepted for European regulatory reviewLSE:GSKGsk Plc
19/07/202408:12Alliance NewsAlliance NewsGSK drug for multiple myeloma accepted for European regulatory reviewLSE:GSKGsk Plc
18/07/202415:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
16/07/202415:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
15/07/202415:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
14/07/202411:18Alliance NewsAlliance NewsGSK moves to new global headquarters in return to central LondonLSE:GSKGsk Plc
14/07/202411:18Alliance NewsAlliance NewsGSK moves to new global headquarters in return to central LondonLSE:GSKGsk Plc
12/07/202415:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
08/07/202413:32Alliance NewsAlliance NewsIN THE KNOW: UBS downgrades GSK and hacks share price targetLSE:GSKGsk Plc
08/07/202413:32Alliance NewsAlliance NewsIN THE KNOW: UBS downgrades GSK and hacks share price targetLSE:GSKGsk Plc
03/07/202409:22Alliance NewsAlliance NewsTOP NEWS: GSK inks licensing deal with CureVac for flu and Covid drugsLSE:GSKGsk Plc
03/07/202409:22Alliance NewsAlliance NewsTOP NEWS: GSK inks licensing deal with CureVac for flu and Covid drugsLSE:GSKGsk Plc
03/07/202407:00RNS Regulatory NewsGSK PLC GSK and CureVac collaboration restructuredLSE:GSKGsk Plc
01/07/202415:00RNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
28/06/202419:43Alliance NewsAlliance NewsIN BRIEF: GSK reaches settlement over Zantac case in IllinoisLSE:GSKGsk Plc
28/06/202419:43Alliance NewsAlliance NewsIN BRIEF: GSK reaches settlement over Zantac case in IllinoisLSE:GSKGsk Plc
28/06/202417:37RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
24/06/202408:55Alliance NewsAlliance NewsTOP NEWS: GSK hails Omjjara approval in Japan; Jemperli review in EULSE:GSKGsk Plc
24/06/202408:55Alliance NewsAlliance NewsTOP NEWS: GSK hails Omjjara approval in Japan; Jemperli review in EULSE:GSKGsk Plc
24/06/202407:05RNS Regulatory NewsGSK PLC Omjjara approved in Japan for myelofibrosisLSE:GSKGsk Plc
24/06/202407:00RNS Regulatory NewsGSK PLC EMA validates Jemperli marketing authorisationLSE:GSKGsk Plc
21/06/202415:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
12/06/202415:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
11/06/202409:32Alliance NewsAlliance NewsTOP NEWS: GSK takes first steps to appeal Zantac ruling in DelawareLSE:GSKGsk Plc
11/06/202409:32Alliance NewsAlliance NewsTOP NEWS: GSK takes first steps to appeal Zantac ruling in DelawareLSE:GSKGsk Plc
11/06/202407:00RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
10/06/202419:00Alliance NewsAlliance NewsTOP NEWS: GSK welcomes dismissal of Zantac case in IllinoisLSE:GSKGsk Plc
 Showing the most relevant articles for your search:LSE:GSK

Your Recent History

Delayed Upgrade Clock